OtherPublished 28 Jan 2022
Development of a Unique Vaccine endowed with Multiple Therapeutic properties
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Many years back, I developed a vaccine against leprosy, which has both immuno-prophylactic and laudable therapeutic properties. It cures ugly leprosy patients to normal beings without any ugly blemishes or scars, so much so that it is difficult to consider the cured person as having ever suffered from leprosy. It received the approval of Drugs Controller General of India and US FDA. It is passed on to a company for making it available to public. The vaccine is based on a cultivable atypical mycobacteria. The gene sequence of this mycobacteria is now known. It has been named as Mycobacterium indicus pranii (MIP). Pran is my family name and nii is the National institute of immunology, of which I was the Founder Director, where the final vaccine development took place. MIP is also highly effective for treatment of Category-II, “Difficult-to-treat” Tuberculosis. It is a potent invigorator of immune response. The company making it, is marketing it under different names for Psoriasis and some cancers It is being employed by the Department of Dermatology, All India Institute of Medical Sciences, New Delhi for impressive treatment of ugly ano-genital warts. We are using MIP as adjuvant in the recombinant anti-hCG Birth Control vaccine currently under development. A totally unforeseen application of MIP has been for treatment for Covid-19 patients as reported in 2 recent publications.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Health and Medical Research
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “G.P. Talwar”
